Other
Blood Pressure Monitoring
0
Pipeline Programs↗
1
Active Trials↗
5
Companies Involved↗
Blood Pressure Monitoring is an early-stage landscape with 0 programs across 5 companies. The most active players are Boehringer Ingelheim, Azurity Pharmaceuticals, Acerus Pharmaceuticals Corporation.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
8
clinical trials
Completed6 · 75%
Not yet recruiting1 · 13%
Unknown status1 · 13%
Clinical Trials
Trial Activity
8 trials
Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy
Completed·—·Phase 4·NCT00295542·3,344 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)